IKS Health Acquires AI Team to Boost Patient Access Solutions, Announces $19M Investment in US Expansion

March 31, 2026
IKS Health Acquires AI Team to Boost Patient Access Solutions, Announces $19M Investment in US Expansion
  • IKS Health CEO Sachin K. Gupta highlighted the strategic importance of integrating ThinkDTM’s AI capabilities to boost revenue optimization and broaden AI development within the company.

  • IKS Health positions its Care Enablement platform as reducing administrative and operational burdens in healthcare by combining agentic AI workflows with human expertise, and the company has earned recognitions such as a Black Book ranking, strong KLAS ratings, and a Google Cloud DORA Award.

  • The press release references a regulatory filing submitted to the National Stock Exchange of India (NSE).

  • Financial terms of the acquihire were not disclosed.

  • The USD 19 million investment followed regulatory disclosure under SEBI LODR Regulations and involved formal communications to BSE and NSE, underscoring compliance and strategic intent to strengthen IKS Inc.’s growth potential.

  • The article includes a standard corporate profile of IKS Health and a brief mention of Inventurus Knowledge Solutions Limited’s NSE/BSE listings and stock codes, followed by unrelated promotional content in German and external links that are not part of the main article.

  • Media inquiries: Sameer Arora (Senior Vice President); Investor inquiries: Saransh Mundra (Vice President); Source: BSE filings are provided for reference.

  • Inventurus Knowledge Solutions Limited trades on the National Stock Exchange of India and BSE, signaling a public-market-backed expansion of its healthcare technology capabilities through acquisitions like ThinkDTM.

  • The announcement includes standard corporate information about IKS Health, its mission, and contact details for media inquiries.

  • Separately, Inventurus Knowledge Solutions announced a USD 19.0 million investment in its wholly owned subsidiary IKS Inc., acquiring 29,541 shares as the first tranche of an approved investment plan, signaling a commitment to expanding its US subsidiary’s operations.

  • Tij Bedi and his AI-focused team will join IKS Health to lead the expansion and transformation of the patient access solutions portfolio, including scheduling, registration, demographic capture, insurance eligibility verification, and prior authorizations.

  • The investment underscores confidence in IKS Inc.’s strategic importance within Inventurus Knowledge Solutions’ broader expansion plans, with regulatory compliance documented by company officers.

Summary based on 8 sources


Get a daily email with more AI stories

More Stories